Knox Capital Affiliate Leads Growth Investment in Prevail Legal

Knox Systems Raises $25M Series A Led by B Capital

March 17, 2026

Cloud & SaaS

Knox Systems, a federal AI-managed cloud provider, raised $25 million in Series A funding to scale its managed platform for delivering FedRAMP authorization in about 90 days at significantly lower cost. The round was led by B Capital with participation from M12, Microsoft’s Venture Fund, Okta Ventures, MongoDB Ventures, Hearst Ventures, and prior investors Felicis, Firsthand, and Ridgeline.

a360inc Acquires ProVest

July 31, 2024

Legal Services

a360inc, a San Antonio–based legal and credit risk technology and outsourcing provider, has acquired ProVest, a Tampa-based process and litigation information services firm that supports creditors, mortgage lenders, servicers and law firms. The transaction included a concurrent investment in a360inc by funds managed by Morgan Stanley Investment Management, Knox Capital and Nonantum Capital Partners to support expanded service offerings and technology integration.

Knox Lane Leads $225M Growth Investment in Pattern

October 6, 2021

E-Commerce

Pattern, the Lehi, Utah–based ecommerce and marketplace acceleration platform, received a $225 million minority growth equity investment led by growth investor Knox Lane with pro‑rata participation from existing investors. The capital will be used to further develop Pattern’s technology and services platform and extend its global presence across marketplaces and direct‑to‑consumer channels. J.P. Morgan served as placement agent; advisors named include William Blair, Jones Day and Kirkland & Ellis.

Eli Lilly and Company to Acquire Prevail Therapeutics

December 15, 2020

Biotechnology

Eli Lilly and Company announced a definitive agreement to acquire Prevail Therapeutics for $22.50 per share in cash, plus a non-tradable contingent value right (CVR) worth up to $4.00 per share, for total consideration of up to approximately $1.04 billion. The acquisition is intended to establish a gene therapy program within Lilly anchored by Prevail’s AAV9-based neuroscience pipeline. Lilly expects the transaction to close in the first quarter of 2021, subject to customary closing conditions and regulatory approvals.

Knox Capital Makes Strategic Growth Investment in Collabtech Group

April 2, 2020

IT Services

Knox Capital Holdings, LLC has made a strategic investment in Collabtech Group to accelerate the collaboration-technology services company’s international expansion and scale its workforce and infrastructure. The capital will support hiring across HR, accounting and sales at Collabtech’s Arizona location as the firm expands its global presence and managed services offering.

Knox Capital Leads Strategic Investment in a360inc

September 18, 2019

Professional Services

a360inc, a Carrollton, Texas-based legal and financial services technology and outsourcing provider, received a strategic growth investment led by Knox Capital and supported by affiliates of Morgan Stanley Private Credit and ORIX Mezzanine & Private Equity. The capital will be used to accelerate technology and service improvements in the creditors' rights market and to pursue add-on acquisitions; terms were not disclosed.